LIMITED COMPETITION FOR EQUIPMENT SUPPLEMENTS TO MBRS SCORE GRANTS
Release Date: December 3, 2001
RFA: RFA-GM-02-006
National Institute of General Medical Sciences (NIGMS)
Letter of Intent Receipt Date: January 11, 2002
Application Receipt Date: February 12, 2002
PURPOSE
Minority Opportunity for Research (MORE) Division, Minority Biomedical
Research Support (MBRS) Branch of The National Institute of General Medical
Sciences (NIGMS) announces a limited initiative to solicit competing
supplemental applications to acquire laboratory equipment. The purpose of
these supplemental grants is to assist Support for Continuous Research
Excellence (SCORE) grantee institutions in acquiring and maintaining
individual pieces of equipment or establishing an equipment core. Although
equipment is an allowable cost in SCORE grants, these supplements should
provide the research faculty with equipment that is either not readily
available or is lacking but that is essential to conducting their research.
The supplemental funds may be used to purchase new equipment or to upgrade
existing equipment for use by investigators in the biological, behavioral or
biomedical related sciences.
HEALTHY PEOPLE 2010
The Public Health Service (PHS) is committed to achieving the health promotion
and disease prevention objectives of "Healthy People 2010", a PHS-led national
activity for setting priority areas. This Request for Applications (RFA),
Limited Competition for Equipment Supplements to MBRS SCORE Grants, is related
to one or more of the priority areas. Potential applicants may obtain a copy
of "Healthy People 2010" at http://www.health.gov/healthypeople/.
ELIGIBILITY REQUIREMENTS
Eligible institutions are those with current MBRS SCORE grants. Institutions
must have at least one year of support remaining at the time of award and the
supplemental award may not extend beyond the parent grant.
MECHANISM OF SUPPORT
Support will be offered as a competing supplement (Type 3) to an existing S06
award. For equipment, this is a one-time solicitation and awards are not
renewable. However, if a technical assistant is required, these costs may be
requested for the duration of the grant period.
FUNDS AVAILABLE
NIGMS intends to commit approximately $3-4 million in FY 2002 to fund
supplemental equipment grants in response to this RFA. Because the nature and
cost of the equipment may vary, it is anticipated that the size of each award
will also vary. Although the financial plans of NIGMS provide support for
this supplement program, awards pursuant to this RFA are contingent upon the
availability of funds and the receipt of a sufficient number of meritorious
applications. At this time, it is not known if this RFA will be reissued.
RESEARCH OBJECTIVES
Background
In the NIH Revitalization Act of 1993, NIH was encouraged to increase the
number of underrepresented minorities participating in biomedical and
behavioral research. In response to the Act, the NIGMS established the MBRS
program which includes the SCORE initiative. The purpose of the MBRS program
is to assist biomedical and behavioral research faculty to develop competitive
research programs at minority-serving institutions, and to increase the number
of underrepresented minority scientists professionally engaged in biomedical
research. In addition, the MBRS Branch recognizes that eligible institutions
are diverse in institutional environment and mission. Therefore, with respect
to evaluation, the SCORE program requires that each institution set its own
goals and measurable objectives that are based on its self assessment and that
it identify anticipated milestones for achievements.
Types of Equipment Requests
Individual Equipment Items: Applicants may request costs for individual
pieces of equipment necessary to facilitate progress in a particular research
subproject. Justification for the equipment should be based on its utility to
drive the research forward and its present unavailability at that institution.
Multi-user research core facilities: Costs for multi-user research core
facilities are allowable. The core may include equipment and services that
will be shared by multiple research subprojects of the program. This may
include items such as autoclaves, dishwashers, cage washers, and computer
servers. A plan for access to the facility, its maintenance, management and
use must be included. The core may also include a technical assistant to
maintain the equipment and instruct faculty and students in its use. To aid
in the review, it is suggested that a tabular summary show the estimated or
actual proportional use of this core component by each project, and other
investigators and students. Justify this core component by discussing ways in
which these centralized services improve quality, bring about an economy of
effort, and/or save overall costs as compared to their inclusion as part of
each research subproject. Plans to maintain the core facility beyond the
grant period should be discussed. Personnel costs to maintain and service the
equipment are an allowable cost. Support for large pieces of equipment,
however, may be limited by the MBRS budget.
SPECIAL REQUIREMENTS
Although requests for equipment should be justified with regard to enhancing
the progress of the research, it should not change the scope of the research
project(s).
Support for equipment for a subproject and/or equipment for core facilities
may be requested. The minimum aggregate cost allowable is $50,000 and the
maximum is $500,000. In addition, when fully justified, support for a
technical assistant to maintain and teach others in the use of the equipment
is allowed.
A progress report will be required as a part of a subsequent non-competing
application (Type 5), competing renewal (Type 2) application, or of the close-
out package if a competing renewal application is not awarded. This progress
report should describe the benefits derived from institution-wide use of the
equipment and provide specific information on overall use of the equipment or
equipment core.
Unallowable Costs
Unallowable costs include:
o Computers for individual use;
o Computers and audiovisual equipment for general classroom use;
o Supplies and other laboratory items whose cost is less than $5,000.
INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS
It is the policy of the NIH that women and members of minority groups and
their sub-populations must be included in all NIH-supported clinical research
projects unless a clear and compelling justification is provided indicating
that inclusion is inappropriate with respect to the health of the subjects or
the purpose of the research. This policy results from the NIH Revitalization
Act of 1993 (Section 492B of Public Law 103-43).
All investigators proposing clinical research should read the AMENDMENT "NIH
Guidelines for Inclusion of Women and Minorities as Subjects in Clinical
Research - Amended, October, 2001," published in the NIH Guide for Grants and
Contracts on October 9, 2001
(http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html);
a complete copy of the updated Guidelines are available at
http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm.
The amended policy incorporates: the use of an NIH definition of
clinical research; updated racial and ethnic categories in compliance with the
new OMB standards; clarification of language governing NIH-defined Phase III
clinical trials consistent with the new PHS Form 398; and updated roles and
responsibilities of NIH staff and the extramural community. The policy
continues to require for all NIH-defined Phase III clinical trials that: a)
all applications or proposals and/or protocols must provide a description of
plans to conduct analyses, as appropriate, to address differences by
sex/gender and/or racial/ethnic groups, including subgroups if applicable; and
b) investigators must report annual accrual and progress in conducting
analyses, as appropriate, by sex/gender and/or racial/ethnic group
differences.
INCLUSION OF CHILDREN AS PARTICIPANTS IN RESEARCH INVOLVING HUMAN SUBJECTS
It is the policy of NIH that children (i.e., individuals under the age of 21)
must be included in all human subjects research, conducted or supported by the
NIH, unless there are scientific and ethical reasons not to include them.
This policy applies to all initial (Type 1) applications submitted for receipt
dates after October 1, 1998.
All investigators proposing research involving human subjects should read the
"NIH Policy and Guidelines" on the Inclusion of Children as Participants in
Research Involving Human Subjects that was published in the NIH Guide for
Grants and Contracts, March 6, 1998, and is available at the following URL
address: http://grants.nih.gov/grants/guide/notice-files/not98-024.html.
Investigators also may obtain copies of these policies from the program staff
listed under INQUIRIES. Program staff may also provide additional relevant
information concerning the policy.
REQUIRED EDUCATION ON THE PROTECTION OF HUMAN SUBJECT PARTICIPANTS
NIH policy requires education on the protection of human subject participants
for all investigators submitting NIH proposals for research involving human
subjects. This policy announcement is found in the NIH Guide for Grants and
Contracts Announcement dated June 5, 2000, at the following website:
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html.
URLS IN NIH GRANT APPLICATIONS OR APPENDICES
All applications and proposals for NIH funding must be self-contained within
specified page limitations. Unless otherwise specified in an NIH
solicitation, internet addresses (URLs) should not be used to provide
information necessary to the review because reviewers are under no obligation
to view the Internet sites. Reviewers are cautioned that their anonymity may
be compromised when they directly access an Internet site.
PUBLIC ACCESS TO RESEARCH DATA THROUGH THE FREEDOM OF INFORMATION ACT
The Office of Management and Budget (OMB) Circular A-110 has been revised to
provide public access to research data through the Freedom of Information Act
(FOIA) under some circumstances. Data that are (1) first produced in a
project that is supported in whole or in part with Federal funds and (2) cited
publicly and officially by a Federal agency in support of an action that has
the force and effect of law (i.e., a regulation) may be accessed through FOIA.
It is important for applicants to understand the basic scope of this
amendment. NIH has provided guidance at:
http://grants.nih.gov/grants/policy/a110/a110_guidance_dec1999.htm.
Applicants may wish to place data collected under this RFA in a public
archive, which can provide protections for the data and manage the
distribution for an indefinite period of time. If so, the application should
include a description of the archiving plan in the study design and include
information about this in the budget justification section of the application.
In addition, applicants should think about how to structure informed consent
statements and other human subjects procedures given the potential for wider
use of data collected under this award.
LETTER OF INTENT
Prospective applicants are asked to submit a letter of intent that contains
the title and grant number of the parent grant, the name, address, and
telephone number of the Principal Investigator (Program Director), and the
number and title of the RFA in response to which the application is being
submitted. If possible, provide a description of the equipment that will be
requested. Although a letter of intent is not required, is not binding, and
does not enter into the review of a subsequent application, the information
that it contains allows NIGMS staff to estimate the potential review workload
and plan the review.
The letter of intent is to be sent to Dr. Ernest D. Marquez listed under
INQUIRIES. The letter of intent receipt date is listed above in the heading
of this RFA.
APPLICATION PROCEDURES
The PHS 398 research grant application instructions and forms (rev. 5/2001) at
http://grants.nih.gov/grants/funding/phs398/phs398.html must be used in
applying for these grants. This version of the PHS 398 is available in an
interactive, searchable format. For further assistance contact GrantsInfo,
Telephone 301/435-0714, Email: GrantsInfo@nih.gov.
The RFA label available in the PHS 398 (rev. 5/2001) application form must be
affixed to the bottom of the face page of the application. Type the RFA
number on the label. Failure to use this label could result in delayed
processing of the application such that it may not reach the review committee
in time for review. In addition, the RFA title and number must be typed on
line 2 of the face page of the application form and the YES box must be
marked. The RFA label is also available at:
http://grants.nih.gov/grants/funding/phs398/label-bk.pdf.
Submit a signed, typewritten original of the application, including the
Checklist, and three signed, photocopies, in one package to:
CENTER FOR SCIENTIFIC REVIEW
NATIONAL INSTITUTES OF HEALTH
6701 ROCKLEDGE DRIVE, ROOM 1040, MSC 7710
BETHESDA, MD 20892-7710
BETHESDA, MD 20817 (for express/courier service)
At the time of submission, two additional copies of the application must be
sent to:
Helen R. Sunshine, Ph.D.
Chief, Office of Scientific Review
National Institute of General Medical Sciences, NIH
Building 45, Room 1 AS.13
45 Center Drive, MSC 6200
Bethesda, Maryland 20892-6200
Applications must be received by the application receipt date listed in the
heading of this RFA. If an application is received after that date, it will
be returned to the applicant without review.
The Center for Scientific Review (CSR) will not accept any application in
response to this RFA that is essentially the same as one currently pending
initial review, unless the applicant withdraws the pending application. The
CSR will not accept any application that is essentially the same as one
already reviewed. This does not preclude the submission of substantial
revisions of applications already reviewed, but such applications must include
an Introduction addressing the previous critique.
APPLICATION CONTENT
Under the Experimental Plan, the PI should provide the information requested
below. This section should not exceed 25 pages overall. Equipment
quotations, letters from collaborators and consultants, and the checklist are
excluded from the page limit.
Section 1: Describe how the requested equipment has (1) relevance to the
institution's goals and specific objectives, (2) immediate utility to specific
research project(s), and (3) how the investigator(s) will take advantage of
unique features of the equipment to enhance progress of the research
project(s). Describe how the requested equipment will provide an innovative
approach to the research being conducted. Describe how the equipment will
significantly enhance the scientific environment in which the research is
being conducted and how it will contribute to the probability of success.
Section 2: Describe the plan for maintenance of the requested equipment and
how the institution will assist in support of the equipment requested.
Section 3: Describe your plans to share data generated from the requested
equipment (if applicable).
Section 4: Complete Section 3 ("Facilities and Administrative Costs") of the
PHS 398 Form Checklist.
REVIEW CONSIDERATIONS
Upon receipt, applications will be reviewed for completeness by the CSR and
responsiveness by NIGMS. Incomplete and/or non-responsive applications will
be returned to the applicant without further consideration. Applications that
are complete and responsive to the RFA will be evaluated for scientific and
technical merit by an appropriate peer review group convened by NIGMS in
accordance with the review criteria stated below. As part of the initial
merit review, all applications will receive a written critique and undergo a
process in which only those applications deemed to have the highest scientific
merit, generally the top half of the applications under review, will be
discussed, assigned a priority score, and receive a second level review by
National Advisory General Medical Sciences Council.
Review Criteria
The goals of NIH-supported research are to advance our understanding of
biological systems, improve the control of disease, and enhance health. In
the written comments reviewers will be asked to discuss the following aspects
of the application in order to judge the likelihood that the proposed research
will have a substantial impact on the pursuit of these goals. Each of these
criteria will be addressed and considered in assigning the overall score,
weighting them as appropriate for each application.
Applications submitted in response to this RFA are supplemental to an existing
award. Since these were previously reviewed using the NIH standard review
criteria, the following review criteria will be used to determine the merit of
the supplemental application for equipment:
Significance:
o For research subproject equipment: Does the requested equipment have
relevance and immediate utility and will the investigator take advantage of
unique features of the equipment to enhance progress of his/her research
project?
o For equipment core: Does the proposed equipment core satisfy the needs of
specific research and pilot projects and is there a plan for coordinating
equipment core use by several faculty members?
Approach:
o For subproject equipment: Is there a plan for its maintenance?
o For equipment core: Is there a plan its maintenance, and if technical
assistance for core is requested, does the technician have the appropriate
background and skills to maintain the equipment and instruct others in its
use?
Innovation:
o For all equipment: Has the investigator shown that the equipment will
provide an innovative approach to accomplishing the original aims of the
research project(s)?
Investigator:
o For subproject equipment: Has the investigator been productive in
documenting his/her research findings in refereed journals? Will this
equipment enhance his/her productivity?
Environment:
o For all equipment: Will the equipment significantly enhance the scientific
environment in which the research is being conducted and contribute to the
probability of success?
o For all equipment: Is there evidence of institutional support?
In addition to the above criteria, in accordance with NIH policy, all
applications will also be reviewed with respect to the following:
o The reasonableness of the proposed budget
The adequacy of the proposed plan to share data, if appropriate.
AWARD CRITERIA
Award criteria that will be used to make award decisions include:
o Scientific merit (as determined by peer review)
o Availability of funds
o Programmatic priorities
INQUIRIES
Inquiries concerning this RFA are encouraged. The opportunity to clarify any
issues or answer questions from potential applicants is welcome.
Direct inquiries regarding programmatic issues to:
Ernest D. Marquez, Ph.D.
Chief, MBRS Branch
National Institute of General Medical Sciences
45 Center Drive, Room Number 2As.37, MSC 6200
Bethesda, MD 20892-6200
Telephone: (301) 594-3900
FAX: (301) 480-2753
E-mail: marqueze@nigms.nih.gov
Direct inquiries regarding review issues to:
Helen R. Sunshine, Ph.D.
Chief, Office of Scientific Review
National Institute of General Medical Sciences, NIH
Building 45, Room 1 AS.13
45 Center Drive, MSC 6200
Bethesda, Maryland 20892-6200
Telephone: (301) 594-2881
FAX: (301) 480-8506
E-mail: sunshinh@nigms.nih.gov
Direct inquiries regarding fiscal matters to:
Antoinette Holland
Grants Management Officer
Grants Management Branch
Division of Extramural Activities
National Institute of General Medical Sciences, NIH
Building 45, Room 2AN.50
45 Center Drive, MSC 6200
Bethesda, Maryland 20892-6200
Telephone: (301) 594-5132
FAX: (301) 480-2554
E-mail: hollanda@nigms.nih.gov
AUTHORITY AND REGULATIONS
This program is described in the Catalog of Federal Domestic Assistance No.
93.375. Awards are made under authorization of Sections 301 and 405 of the
Public Health Service Act as amended (42 USC 241 and 284) and administered
under NIH grants policies and Federal Regulations 42 CFR 52 and 45 CFR Parts
74 and 92. This program is not subject to the intergovernmental review
requirements of Executive Order 12372 or Health Systems Agency review.
The PHS strongly encourages all grant recipients to provide a smoke-free
workplace and promote the non-use of all tobacco products. In addition,
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain
facilities (or in some cases, any portion of a facility) in which regular or
routine education, library, day care, health care, or early childhood
development services are provided to children. This is consistent with the
PHS mission to protect and advance the physical and mental health of the
American people.
Return to NIH Guide Main Index
|
Office of Extramural Research (OER) |
|
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
|
Department of Health and Human Services (HHS) |
|
||||
|
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |
||||||||||